As previous studies suggested, regarding inflammatory processes in colon cancer, AA CRC patients appear to be characterized by tumors with higher frequency of KRAS mutations and unique mutations in specific genes associated with CRC risk (6, 25), as well as a more pronounced inflammatory response compared to CA patients (7, 8). This evidence concerns the gene KRAS and colorectal carcinoma.